Suppr超能文献

通过与血型物质、血型A和B活性寡糖及其他寡糖进行竞争结合试验,对单叶豆凝集素I的特异性进行研究。

A study of the specificity of Bandeiraea simplicifolia lectin I by competitive-binding assay with blood-group substances and with blood-group A and B active and other oligosaccharides.

作者信息

Kisailus E C, Kabat E A

出版信息

Carbohydr Res. 1978 Nov;67(1):243-55. doi: 10.1016/s0008-6215(00)83746-5.

Abstract

The specificity of Bandeiraea simplicifolia lectin I (BS I) has been studied by competitive-binding assays (CBA) using tritium-labeled human B and hog A substances. Blood-group B substances isolated from horse gastric mucosae and from human ovarian-cyst fluids were much better inhibitors of binding of tritiated blood-group B substance to insoluble BS I-Sepharose 2B than were human blood-group A substances from saliva and ovarian-cyst fluid. A and B active blood-group substances showed the same range of potency in inhibiting binding of tritium-labeled hog A substance to BS I-Sepharose 2B. CBA with BS I-Sepharose 2B, labeled human blood-group B substance, and human blood-group A and B active aligosaccharides separated the haptens into two groups differing in slope. Group 1, containing methyl alpha-D-GalNAcp, D-GalNAcp, and an A active pentasaccharide ARL 0.52, with 3, 19, and 25 nmol respectively needed for 50% inhibition of binding, has a lower slope than group 2, which contains alpha-D-GalNAcp-(1 leads to 3)-2-acetamido-2-deoxy-D-galactitol and p-nitrophenyl alpha-D-GalNAcp, with 3 nmol of each required for 50% inhibition of binding, as well as ten glycosides with terminal, nonreducing, alpha-linked D-Galp. The most potent inhibitors of this group were p-nitrophenyl alpha-D-Galp, alpha-D-Galp-(1 leads to 3)-D-Galp, alpha-D-Galp-(1 leads to 6)-D-Glcp, and methyl alpha-D-Galp, with 5, 7.4, 9.6, and 11 nmol respectively needed to inhibit binding by 50%. The difference in slopes was explainable in terms of a recent finding that BS I exists as a mixture of five isolectins composed of two subunits having different specificities; subunit A is most specific for alpha-linked, terminal, nonreducing D-GalNAcp, but it also reacts with alpha-linked, terminal, nonreducing D-Galp, whereas subunit B tends to be more specific for terminal, nonreducing, alpha-linked D-Galp.

摘要

利用氚标记的人B物质和猪A物质,通过竞争结合试验(CBA)研究了单叶豆凝集素I(BS I)的特异性。从马胃黏膜和人卵巢囊肿液中分离出的B血型物质,比从唾液和卵巢囊肿液中提取的人A血型物质,能更好地抑制氚标记的B血型物质与不溶性BS I-琼脂糖2B的结合。A和B活性血型物质在抑制氚标记的猪A物质与BS I-琼脂糖2B结合方面表现出相同的效价范围。用BS I-琼脂糖2B、标记的人B血型物质以及分离出的人A和B活性低聚糖进行CBA,可将这些半抗原分为两组,其斜率不同。第1组包含α-D-氨基半乳糖甲基酯、D-氨基半乳糖以及一种A活性五糖ARL 0.52,50%抑制结合分别需要3、19和25 nmol,其斜率低于第2组,第2组包含α-D-氨基半乳糖-(1→3)-2-乙酰氨基-2-脱氧-D-半乳糖醇和对硝基苯基α-D-氨基半乳糖,50%抑制结合各需要3 nmol,以及十种具有末端、非还原、α-连接的D-半乳糖的糖苷。该组中最有效的抑制剂是对硝基苯基α-D-半乳糖、α-D-半乳糖-(1→3)-D-半乳糖、α-D-半乳糖-(1→6)-D-葡萄糖以及α-D-半乳糖甲基酯,50%抑制结合分别需要5、7.4、9.6和11 nmol。斜率的差异可以根据最近的一项发现来解释,即BS I以由具有不同特异性的两个亚基组成的五种同工凝集素的混合物形式存在;亚基A对α-连接的、末端的、非还原的D-氨基半乳糖最具特异性,但它也与α-连接的、末端的、非还原的D-半乳糖反应,而亚基B往往对末端的、非还原的、α-连接的D-半乳糖更具特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验